Status:
COMPLETED
Impact of New Variants and Vaccines on the Course of COVID-19
Lead Sponsor:
Izmir Katip Celebi University
Conditions:
COVID-19
Brief Summary
Novel coronavirus disease (COVID-19), caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, was first reported in December 2019 in Wuhan, China. The disease has spread to many ...
Detailed Description
Novel coronavirus disease (COVID-19), caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, was first reported in December 2019 in Wuhan, China. The disease spread to many coun...
Eligibility Criteria
Inclusion
- \- All patients with a confirmed diagnosis of COVID-19 by PCR testing
Exclusion
- Under 18 years old
- Clinical outcome cannot be followed
- Patients with severe trauma
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 19 2022
Estimated Enrollment :
15967 Patients enrolled
Trial Details
Trial ID
NCT05384886
Start Date
January 1 2022
End Date
May 19 2022
Last Update
May 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IKCU, Atatürk Eğitim ve Araştırma Hastanesi, Acil Tıp
Izmir, Turkey (Türkiye), 35360